Results for tag: "Leuprorelin"

Leuprorelin is a synthetic hormone used in the treatment of certain types of cancer. It is a gonadotropin-releasing hormone agonist (GnRH agonist) used to treat prostate cancer, endometriosis, and uterine fibroids. It works by blocking the production of certain hormones that stimulate the growth of cancer cells. It is also used to treat precocious puberty, a condition in which children begin puberty at an abnormally early age. Leuprorelin is available in both injectable and implantable forms. The injectable form is administered intramuscularly or subcutaneously, while the implantable form is inserted under the skin. The implantable form is designed to slowly release the drug over a period of time, usually three to six months. Leuprorelin is a widely used drug in the oncology market. It is used to treat a variety of cancers, including prostate, breast, ovarian, and endometrial cancer. It is also used to treat precocious puberty and uterine fibroids. Some companies in the leuprorelin market include Pfizer, Novartis, Sanofi, and AstraZeneca. Show Less Read more